FDA Inspection
Bioreliance CorporationBioreliance Corporation – FDA Inspection, May 14, 2014
Record Details
This FDA Inspection record concerns Bioreliance Corporation, with an inspection on May 14, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bioreliance Corporation
- Inspection Date
- May 14, 2014
- Product Type
- Drugs
View Company Profile
ID · 1323116a-d6ef-4b45-870f-493709f1e032
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 879780
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bioreliance Corporation
11| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2026 | VAI | Baltimore District Office | Bioresearch Monitoring: Human Drugs |
| November 22, 2024 | VAI | Baltimore District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| August 4, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2019 | Not classified | Baltimore District Office | |
| July 13, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Bioreliance Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.